Recommended old and new childhood vaccination schedule in Iraq
| Age | Vaccine | Old schedule | New schedule | No of doses | Price per dose (US$) | Vaccine wastage (%) |
| At birth | BCG | X | X | 1 | 0.19 | 50 |
| Hepatitis B | X | X | 1 | 0.55 | 25 | |
| OPV | X | X | 1 | 0.22 | 25 | |
| <1 year | DTaP-IPV-HepB-Hib | X | 3 | 20.65 | 5 | |
| DTwP-HepB-Hib | X | 3 | 0.69 | 13 | ||
| PCV13 | X | X | 3 | 18.77 | 5 | |
| OPV | X | X | 3 | 0.22 | 25 | |
| IPV | X | 2 | 2.95 | 13 | ||
| Rotavirus | X | X | 2 | 6.65 | 5 | |
| Measles | X | X | 1 | 0.70 | 40 | |
| 1–6 years | OPV | X | X | 2 | 0.22 | 25 |
| DTaP-Hib-IPV | X | 1 | 14.89 | 5 | ||
| MMR | X | X | 2 | 3.18 | 40 | |
| DTaP-IPV | X | 1 | 10.58 | 5 | ||
| DTwP | X | 2 | 0.17 | 20 |
aP, acellular pertussis; HiB, haemophilus influenzae type b; IPV, inactivated polio vaccine; MMR, measles-mumps-rubella; OPV, Oral Polio Vaccine; PCV13, 13-valent Pneumococcal Conjugate vaccine; wP, whole-cell pertussis.